Original news and analysis on international IP policy
A newly leaked 2016 letter from the CEO of Novartis to the president of Colombia, made available by Swiss group Public Eye, shows the level of concern the Swiss pharmaceutical company had over the effect of possible issuance of a compulsory licence for Novartis drug Glivec in the pivotal South American economy.
BERN, Switzerland -- What if reaching the United Nations Sustainable Development Goals on access to health for all depended on the willingness of all actors to see beyond outdated dichotomies? The concept may seem obvious, but is easier described than done. In an effort to break silos, the Swiss Federal Institute of Intellectual Property (IPI) brought together stakeholders of all sides last week to discuss how to harness political and economic will to achieve innovation leading to new medicines that are available and affordable for all in need.
By a vote of 94-0, the United States Senate on 5 February confirmed California intellectual property litigator Andrei Iancu as next director of the US Patent and Trademark Office (USPTO). The new Under Secretary of Commerce for Intellectual Property is currently managing partner of Irell & Manella LLP’s Los Angeles firm. The patent and trademark communities wished Iancu luck but said there are many issues at the agency that need his attention.
Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance.
Mirza Alas of the intergovernmental South Centre has published an analysis of the World Health Organization Executive Board approval of a draft resolution on actions toward ending tuberculosis and how it relates to antimicrobial resistance (AMR). The opening paragraphs and a link to the original are provided below.
Richard Hill writes: The Tunis Agenda calls for enhanced cooperation to address issues related to the Internet and its governance. However, there was no clear agreement on how to implement enhanced cooperation, so a Working Group on Enhanced Cooperation (WGEC) was convened to discuss that matter and to prepare recommendations. A first WGEC group failed to find agreement, so a second group was formed. In 2018, fifteen years later, the digital divide is worse, spam is worse, and security and privacy have become key issues; the fact that ICANN operates under the jurisdiction of the USA is also at times raised. Some are of the view that the evidence shows that current mechanisms are not working.
The International Generic and Biosimilar medicines Association has launched an information campaign on biosimilar medicines in order to raise worldwide understanding and acceptance of biosimilar medicines.
The protection of genetic resources and traditional knowledge through the intellectual property system has been discussed for many years at the World Intellectual Property Organization. While delegates are working on potential international instruments to provide such protection, the WIPO Traditional Knowledge Division is involved in technical assistance and capacity building, providing information and issuing publications.
The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week's Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed.
The Foundation for Innovative New Diagnostics (FIND) yesterday announced the release of a new strategy on antimicrobial resistance (AMR).
Friends and followers of the nation and culture of India gathered in Geneva this week to celebrate India's Republic Day, with a ceremony and feast held in the halls of the UN World Intellectual Property Organization. Among the many achievements and areas of growth mentioned of the rising economy was its prowess in generic medicines production.
Ed Klaris writes: Recently, a photographer whose camera was used by a monkey to take a selfie settled a two-year legal battle against an animal rights group about copyright over the image. The lower court had denied the monkey a copyright, but the photographer did not want to face the appeals court. Whether monkeys can create copyrighted works is not exactly a pressing question for our time. But the important issues raised by this case and others about who owns creative work in an increasingly automated world are crucial to the future of copyright. With the advent of AI software, computers -- not monkeys -- will potentially create millions of original works that may then be protected by copyright, under current law, for more than 100 years.